Discontinuation report BICALUTAMIDE
| Report ID | 86436 |
| Drug Identification Number | 02382423 |
| Brand name | BICALUTAMIDE |
| Common or Proper name | BICALUTAMIDE |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | BICALUTAMIDE |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | L02BB |
| ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2019-12-01 |
| Actual discontinuation date | 2020-02-18 |
| Remaining supply date | 2020-02-18 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-02-21 | French | Compare |
| v5 | 2020-02-21 | English | Compare |
| v4 | 2019-09-18 | French | Compare |
| v3 | 2019-09-18 | English | Compare |
| v2 | 2019-06-12 | French | Compare |
| v1 | 2019-06-12 | English | Compare |
Showing 1 to 6 of 6